Cost-effectiveness of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors in the secondary prevention of cardiovascular disease: forecasting the incremental benefits of preventing coronary and cerebrovascular events (Q40820541)
Jump to navigation
Jump to search
scientific article published on March 1999
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cost-effectiveness of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors in the secondary prevention of cardiovascular disease: forecasting the incremental benefits of preventing coronary and cerebrovascular events |
scientific article published on March 1999 |
Statements
1 reference
Cost-effectiveness of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors in the secondary prevention of cardiovascular disease: forecasting the incremental benefits of preventing coronary and cerebrovascular events (English)
1 reference
Grover SA
1 reference
Coupal L
1 reference
Paquet S
1 reference
Zowall H
1 reference
1 March 1999
1 reference
1 reference
159
1 reference
6
1 reference
593-600
1 reference
Identifiers
1 reference
1 reference